Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fentanyl and Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound-guided Superficial Cervical Plexus Block in Thyroid Surgeries

NCT07057739 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT07057739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07057739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fentanyl and Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound-guided Superficial Cervical Plexus Block in Thyroid Surgeries
Lead sponsor
Kafrelsheikh University
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2024
Completion date
May 30, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvants, bupivacaine, dexmedetomidine, fentanyl, superficial cervical plexus block, thyroid surgeries, ultrasound